Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model

Journal of Experimental Medicine

Volumn 188, Issue 2, 1998, Pages 223-232

  Moskophidis, Demetrius ^a   Kioussis, Dimitris ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

CD8+ cytotoxic T lymphocytes; Influenza A virus; Influenza viral pneumonia; Interferon ; T cell receptor transgenic mice

Indexed keywords

CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS EXCRETION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; MICE; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0031824006     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.2.223     Document Type: Article

References (79)

1. Palese, P., and J.F. Young. 1982. Variation of influenza A. B. and C viruses. Science. 215:1468-1474.
2. Webster, R.G., W.G. Laver, and G.M. Air. 1983. Antigenic variation among type A influenza viruses. In Genetics of Influenza Viruses. P. Palese and D.W. Kingsbury, editors. Springer-Verlag. Vienna/New York. 127-168.
3. Gorman, O.T., W.J. Bean, and R.G. Webster. 1992. Evolutionary processes in influenza viruses: divergence, rapid evolution, and stasis. Curr. Top. Microbiol. Immunol. 176:75-97.
4. Yewdell, J.W., R.G., Webster, and W. Gerhard. 1979. Antigen variation in three distinct determinants of an influenza A haemagglutinin molecule. Nature. 279:246-248.
5. Townsend, A.R.M., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601-624.
6. Ada, G.L., and P.D. Jones. 1986. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128:1-54.
7. Doherty, P.C., W. Allan, M. Eichelberger, and S.R. Carding. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
8. McMicheal, A. 1994. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189:75-91.
9. Eichelberger, M.C., M.L. Wang, W. Allan, R.G. Webster, and P.C. Doherty. 1991. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J. Gen. Virol. 72: 1695-1698.
10. Roth, M.G., J.P. Fitzpatrick, and R.W. Compans. 1974. Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. Proc. Natl. Acad. Sci. USA. 76:6430-6434.
11. Kilbourne, E.D. 1987. Influenza. Plenum Medical Book Co., New York. 359 pp.
12. Owen, J.A., K.I. Dudzik, L. Klein, and D.K. Dorer. 1988. The kinetics and generation of influenza-specific cytotoxic T-lymphocyte precursor cells. Cell. Immunol. 111:247-252.
13. Allan, W., Z. Tabi, A. Cleary, and P.C. Doherty. 1990. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144:3980-3986.
14. Muellbacher, A. 1994. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179:317-321.
15. Murphy, B.R., and R.G. Webster. 1996. Orthomyxoviruses. In Fields Virology. 3rd ed., Vol. 1. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. 2 vols. Lippincott-Raven Publishers, Philadelphia. 1397-1445.
16. Steinhoff, M.C., L.F. Fries, R.A. Karron, M.L. Clements, and B.R. Murphy. 1993. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. J. Clin. Microbiol. 31:836-838.
17. Frank, A.L., L.H. Taber, W.P. Glezen, A. Paredes, and R.B. Couch. 1979. Reinfection with influenza A (H3N2) virus in young children and their families. J. Infect. Dis. 140:829-836.
18. Epstein, S.L., C.-Y. Lo, and J.R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:322-327.
19. Graham, M.B., and T.J. Braciale. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186:2063-2068.
20. Topham, D.J., and P.C. Doherty. 1998. Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J. Virol. 72:882-885.
21. Taylor, P.M.A., and B.A. Askonas. 1986. Influenza nucleo-protein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 58:417-420.
22. Wraith, D.C., A.E. Vessey, and B.A. Askonas. 1987. Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68:433-440.
23. Andrew, M.E., and B.E.H. Coupar. 1988. Efficacy of influenza hemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Scand. J. Immunol. 25:81-85.
24. Tite, J.P., C. Hughes-Jenkins, D. O'Callagham, G. Dougan, S.M. Russell, X.-M. Gao, and F.Y. Liew. 1990. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology. 71:202-207.
25. Webster, R.G., Y. Kawaoka, J. Taylor, K. Weinberg, and E. Paoletti. 1991. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine. 9:303-308.
26. Epstein, S.L., J.A. Misplon, C.M. Lawson, E.K. Subbarao, M. Connors, and B.R. Murphy. 1993. β2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150:5484-5493.
27. Lawson, C.M., J.R. Bennink, N.P. Restifo, J.W. Yewdell, and B.R. Murphy. 1994. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 68:3505-3511.
28. Mamalaki, C., T. Norton, Y. Tanaka, A.R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1992. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 89: 11342-11346.
29. Mamalaki, C., J. Elliott, T. Norton, N. Yannoutsos, A.R. Townsend, P. Chandler, E. Simson, and D. Kioussis. 1993. Positive and negative selection in transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and endogenous superantigen. Dev. Immunol. 3:159-174.
30. Spanopoulou, E., C.A.J. Roman, L.M. Corcoran, M.S. Schlissel, D.P. Silver, D. Nemazee, M.C. Nussenzweig, S.A. Shinton. R.R., Hardy, and D. Baltimore. 1994. Functional immunoglobulin transgenes guide ordered B-cell differentiation in RAG-1-deficient mice. Genes Dev. 8:1030-1042.
31. Corbela, P., D. Moskophidis, E. Spanopoulou, C. Mamalaki, M. Tolaini, A. Itano, D. Lans, D. Baltimore, E. Kobey, and D. Kioussis. 1994. Functional commitment to helper T cell lineage precedes positive selection and is independent of T cell receptor MHC specificity. Immunity. 1:269-276.
32. Townsend, A.R., F.M. Gotch, and J. Davey. 1985. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell. 42:457-467.
33. Barrett, T., und S.C. Inglis. 1991. Growth, purification and titration of influenza viruses. In Virology, A Practical Approach, B.W. Mahy, editor. IRL Press, Washington, DC. 119-150.
34. Simpson, R.W., and G.K. Hirst. 1961. Genetic recombination among influenza viruses. I. Cross reactivation of plaque-forming capacity as a method for selecting recombinants from the progeny of crosses between influenza A strains. Virology. 15:436-451.
35. Reed, L.J., and H. Muench. 1936. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
36. Moskophidis, D., and F. Lehmann-Grube. 1984. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. J. Immunol. 133: 3366-3370.
37. Skehel, J.J., and G.C. Schild. 1971. The polypeptide composition of influenza A viruses. Virology. 44:396-408.
38. 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 14:181-196.
39. Sarawar, S.R., M. Sangster, R.L. Coffman, and P.C. Doherty. 1994. Administration of anti-IFN-γ antibody to β2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J. Immunol. 153:1246-1253.
40. Finkelman, F.D., I.M. Katona, T.R. Mosmann, and R.L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140: 1022-1027.
41. Scott, P. 1991. Host and parasite factors regulating the development of CD4+ T-cell subsets in experimental cutaneous leishmaniasis. Res. Immunol. 142:32-36.
42. Burns, W.H., L.C. Billups, and A.L. Notkins. 1975. Thymus dependence of viral antigens. Nature. 256:654-662.
43. Virelizier, J.L., A.C. Allison, and G.C. Schild. 1979. Immune response to influenza virus in the mouse and their role in control of infection. Brit. Med. Bull. 35:65-68.
44. Pircher, H.-P., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R.M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:629-633.
45. Moskophidis, D., and K.M. Zinkernagel. 1996. Immunobiology of cytotoxic T-cell resistant variants: studies on lymphocytic choriomeningitis virus (LCMV). Semin. Virol. 7:3-11.
46. Schwarz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science. 248:1349-1356.
47. Herman, A., J.W. Kappler, P. Marrack, and A.M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunoll. 9:745-772.
48. Rocha, B., and H. von Boemer. 1991. Peripheral selection of the T cell repertoire. Science. 251:1225-1228.
49. Schonrich, G., U. Kalinke, F. Momburg, M. Malisen, A.M. Schmitt-Verhulst, B. Malissen, G.J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell. 65:293-304.
50. Moskophidis, D., F. Lechner, H.-P. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected mice by exhaustion of antiviral cytotoxic T cells. Nature. 362:758-761.
51. Webb, S., C., Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T lymphocytes: clonal elimination as consequence of immunity. Cell. 63:1249-1256.
52. Oehen, S., H. Hengartner, and R.M. Zinkernagel. 1991. Vaccination for disease. Science. 251:195-198.
53. Cannon, M.J., P.J. Openshaw, and B.A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
54. Battegay, M., S. Oehen, M. Schulz, H. Hengartner, and R.M. Zinkernagel. 1992. Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. J. Virol. 66:1199-1201.
55. Kim, H.W., J.G. Canchola, C.D. Brandt, G. Pyles, R.M. Channock, K. Jensen, and R.H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigen inactivated vaccine. Am. J. Epidemiol. 89:422-434.
56. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
57. Doherty, P.C., 1996. Immune response to viruses. In Clinical Immunology, Principles and Practice. Vol. I. R.R. Rich, T.A. Fleisher, B.D. Schwarz, W.T. Shearer, and W. Strober, editors. 2 vols. Mosby-Year Book, Inc., St. Louis. 535-549.
58. Doherty, P.C., W. Allan, D.B. Boyle, B.E.H. Coupar, and M.E. Andrew. 1989. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus. J. Infect. Dis. 115:1119-1122.
59. Yap, K.L., G.L. Ada, and I.F. McKenzie. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature. 273:238-239.
60. Lin, Y.L., and B.A. Askonas. 1981. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of dilayed-type hypersensitivity reactions. J. Exp. Med. 154:225-234.
61. Lukacher, A.E., V.L. Braciale, and T.J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814-826.
62. Wells, M.A., F.A. Ennis, and P. Albrecht. 1981. Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J. Immunol. 126:1042-1046.
63. Bennink, J., R.B. Effros, and P.C. Doherty. 1978. Influenza pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology. 35:503-509.
64. McMichael, A.J., F.M. Gotch, G.R. Noble, and P.A.S. Beare. 1983a. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 301:13-17.
65. Kagi, D., and H. Hengartner. 1996. Different roles of cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:472-477.
66. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Watzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
67. Topham, D.J., R.A. Tripp, and P.C. Doherty. 1997. CD8+ T cells clear influenza virus by perform or Fas-dependent processes. J. Immunol. 159:5197-5200.
68. Graham, M.B., D.K. Dalton, D. Giltinan, V.L. Braciale, T.A. Stewart, and T.J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178:1725-1732.
69. Martin, S.K., V. Maruta, S. Burkart, S. Gillis, and H. Kolb. 1988. IL-1 and IFNγ increase vascular permeability. Immunology. 64:301-3115.
70. Baumgarth, N., and A. Kelso. 1996. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 70:4411-4418.
71. McMichael, A.J., F.M. Gotch, P. Cullen, B.A. Askonas, and R.G. Webster. 1981. The human cytotoxic T cell response to influenza A vaccination. Clin. Exp. Immunol. 43:276-285.
72. Webster, R.G., and B.A. Askonas. 1980. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:396-401.
73. Bennink, J.R., J.W. Yewdell, G.L. Smith, C. Moller, and B. Moss. 1984. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature. 311:578-579.
74. Gao, X.M., B. Zheng, F.Y. Liew, S. Brett, and J.P. Tite. 1991. Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by synthetic peptides. J. Immunol. 147:3268-3273.
75. Oukka, M., J.C. Manuguerra, N. Livaditis, S. Tourdot, N. Riche, I. Vergnon, P. Cordopatis, and K. Kosmatopulos. 1996. Protection against lethal infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3039-3045.
76. Ulmer, J.B., J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felger, V.J. Dwarki, S.H. Gromkowski, R.R. Deck, C.M. DeWitt, A. Friedman, et al. 1993. Heterolous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1745-1749.
77. Pertmer, T.M., T.R. Roberts, and J.R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70: 6119-6125.
78. Fulginiti, V.A., J.J. Eller, A.W. Downie, and C.H. Kempe. 1967. Atypical measles in children previously immunized with inactivated measles virus vaccine. JAMA (J. Am. Med. Assoc.). 202:1075-1080.
79. Wells, M.A., P. Albrecht, and F.A. Ennis. 1980. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 126:1036-1041.